bioMérieux, a global leader in the field of in vitro diagnostics, released its business review for fourth-quarter and full-year 2008.
Asia
Europe, Middle East, Africa
North America
bioMérieux - 2008 Business Review
20 January, 2009
bioMérieux's New TEMPO® Solution Delivers Rapid Results on Direct Enumeration of Yeast and Molds to Improve Food Safety
15 January, 2009
bioMérieux, a world leader in the field of in vitro diagnostics, is enhancing its TEMPO® line for food quality with the launch of one of the most rapid automated solutions for direct enumeration of yeast and mold. TEMPO YM delivers final results in half the time versus most other methods, including the ISO reference method (ISO 21527).
Appointment of Alexandre Mérieux by the bioMérieux Board of Directors
22 December, 2008
At the meeting of the bioMérieux Board of Directors held on December 19, 2008, Alexandre Mérieux was appointed as “Directeur Général Délégué” of the Company. Stéphane Bancel continues to be responsible for all functions in his role as Chief Executive Officer and to chair the bioMérieux Management Committee.
Laboratory Customers Name bioMérieux "Top of Class" for Microbiology
17 December, 2008
Magazine survey recognized bioMérieux based on customer support, reliable instrumentation, and rapid response.
Three Clinical Studies of bioTheranostics Molecular Breast Cancer Diagnostics Presented at San Antonio Breast Cancer Symposium
14 December, 2008
Independent studies validate the utility of Theros BCISM for improving risk stratification of early stage breast cancer patients.
bioMérieux Acquires Culture Media Specialist PML Microbiologicals; bioMérieux's Recurring Sales Will be Boosted by Expanded Reagent Range
08 December, 2008
bioMérieux, a world leader in the field of in vitro diagnostics has acquired PML Microbiologicals Inc., a leading provider of culture media and microbiological products in North America for both clinical and industrial applications. This privately held American in vitro diagnostics company has manufacturing and marketing teams based in Portland, Oregon and Toronto, Canada.
bioMérieux Business Review for the Nine Months Ended September 20, 2008
28 October, 2008
bioMérieux, a global leader in the field of in vitro diagnostics, today released its business review for the nine months ended September 30, 2008.
bioMérieux Receives Prestigious Frost & Sullivan 2008 North American Market Leadership Award for Pharmaceutical Microbiology - bioMérieux Recognized for Outstanding Vision in U.S. Rapid Pharmaceutical Manufacturing Microbiology Tests Market
14 October, 2008
bioMérieux, a world leader in the field of in vitro diagnostics, is proud to announce that it is the recipient of the Frost & Sullivan 2008 North American Market Leadership Award for Pharmaceutical Microbiology.
U.S. Lab Professionals Indicate Urgency for Automated Solutions
09 October, 2008
Survey conducted at AACC conference stresses need for laboratory automation to offset Staff Shortages and improve Turn Around Time for Tests.
bioMérieux to Break Ground on Eco-Friendly Facility on the Hazelwood Campus
06 October, 2008
October 6 groundbreaking ceremony expands company’s presence in the U.S.